CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for patients with Hard-to-Treat nerve disease
Disease control Recruiting nowThis study is testing whether an investigational drug called riliprubart can help adults with a chronic nerve disorder called CIDP when standard treatments like steroids or immunoglobulins have not worked well enough. Participants will receive either riliprubart or a placebo (ina…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tracking a new Treatment's Real-World impact on debilitating nerve disease
Disease control Recruiting nowThis study aims to understand how well a medication called efgartigimod works for people with CIDP in real-world settings, outside of a controlled clinical trial. It will follow 200 adults with CIDP for up to two years after they start this treatment, tracking their symptoms, dai…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for nerve disease: major trial tests potential CIDP treatment
Disease control Recruiting nowThis study is testing whether an investigational medicine called empasiprubart is safe and can help adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a nerve disorder that causes weakness and disability. For the first 6 months, some participants will receive t…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists test 'Universal' cell therapy to tame rogue immune system in devastating diseases
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy for people with severe neurological autoimmune diseases that have not responded to other treatments. The therapy, called universal CAR T-cells, is designed to be given 'off-the-shelf' to target and reduce specific immun…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Could a simple ultrasound scan spot nerve damage sooner?
Diagnosis Recruiting nowThis study is testing whether ultrasound imaging of nerves can help doctors diagnose Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) earlier than current methods. Researchers will perform nerve ultrasounds and standard nerve test…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Sponsor: Assiut University • Aim: Diagnosis
Last updated Mar 03, 2026 14:06 UTC